TRIN shorts rebuild as options signal eases

Trinity Capital heads into the week after its Q3 earnings with short sellers quietly rebuilding positions, even as options traders are growing more relaxed than they have been in months.

Short interest has risen sharply. It climbed 12% over the past week to 7.5% of the free float, with the daily estimate hitting 5.7 million shares on November 3. The move is a reversal from mid-October, when SI was running closer to 5.6 million shares after touching a 30-day low around October 21. What makes the rebuild notable is that it has accelerated after the earnings print, suggesting the results themselves gave short sellers something to work with. The ORTEX short score, which aggregates lending and positioning signals, rose to 65 from 61 at the start of last week, ranking in just the 8th percentile of its universe, a genuinely elevated reading.

The lending market tells a more cautious story for anyone looking to add to those shorts. Availability has tightened materially, dropping to 34% from 48% a week ago and 73% at the end of October. That means the pool of shares available to borrow relative to those already lent is shrinking fast. The 52-week low in availability was 0.2%, so there is still room for further tightening, but the direction of travel is clear. Cost to borrow remains modest at around 1.03%, up about 11% over the week but not yet at levels that make short positions expensive to hold.

Options positioning cuts in the opposite direction to short interest. The put/call ratio has dropped to 0.66, well below its 20-day average of 0.95, sitting roughly one standard deviation below the mean. That is the most call-heavy positioning seen on TRIN in months, contrasting sharply with where things were in late September and early October, when the PCR ran above 1.6 and hedging demand dominated. The shift in options tone since mid-October has been pronounced: the ratio has more than halved as call volume has picked up. That divergence, shorts building while options traders lean bullish, is the central tension in the stock right now.

On the Street, the analyst picture is thin and somewhat stale. Keefe, Bruyette and Woods raised its price target to $16.50 in August, maintaining a Market Perform rating. The consensus sits at buy, with a mean target of $18.50 against the current price of $17.05, implying modest upside. The bear case centres on declining core yields, a 2.2% NAV drop to $13.05, and operating earnings missing estimates. Bulls point to leverage rising to 1.15x as a deliberate growth move and to the company's yield profile, which the dividend factor score ranks in the 99th percentile of its coverage universe. The P/E multiple has drifted down about 0.19 points over the past 30 days to 8.1x, and price-to-book has eased to 1.25x, so valuation has softened modestly alongside the 3% one-month price decline.

One attention signal worth noting: ORTEX's retail attention indicator, which blends Wikipedia article views with ORTEX page traffic, logged a z-score of 4.1 as of October 21. That is a sharp spike in retail interest relative to the stock's own 90-day history. It does not carry a measured link to fundamentals, but it does suggest more eyes on TRIN than usual, likely driven by the earnings event.

BDC peers all gained on the week, with OCSL up 4.6%, FSK up 4.4%, and BCSF up 4.1%. TRIN's 1.5% weekly gain trails the peer group, which may partly explain why short interest has been climbing: relative underperformance in a rising tape is a classic short-seller signal in income-oriented names.

What to watch next is whether availability continues tightening into the coming weeks, and whether the gap between rebuilding short interest and call-heavy options positioning resolves through price action or through one side capitulating before the February earnings date.